TSOI Patents List

Post Reply
Posts: 3822
Joined: Fri Jun 26, 2020 5:22 am

TSOI Patents List

Post by trader32176 »

TSOI Patents and Applications filed by date = 58


11-01-2021 Induction of Concurrent Pulmonary Immune Modulation and Regeneration by Protein Mediated Conjugation of Immune Regulatory Cells with Endogenous Progenitor Cells
10-11-2021 Umbilical Cord Derived Regenerative and Immune Modulatory Stem Cell Populations
10-04-2021 Reduction of Neutrophil Extracellular Trap formation by Mesenchymal Stem Cells and their Exosomes
09-22-2021 Stimulation of Mesenchymal Stem Cell Therapeutic Activities by T Regulatory Cells
09-16-2021 Ivermectin Compositions for Treatment of COVID-19
08-23-2021 Umbilical Cord Mesenchymal Stem Cells for Treatment of Chronic Obstructive Pulmonary Disease and Lung Degeneration
08-18-2021 Enhancement of Umbilical Cord Mesenchymal Stem Cell Therapeutic Activity by Stimulators of T Regulatory Cells and/or Cells Expressing CD73
08-11-2021 Induction of Neurogenesis using Umbilical Cord Derived Mesenchymal Stem Cells and Derivatives Thereof
07-06-2021 Treatment of Parkinson’s Disease by Immune Modulation and Regenerative Means
05-24-2021 Immunotherapies for Targeting of Tumor Vasculature
05-21-2021 Lithium as a Monotherapy and/or Stem Cell Adjuvant Therapy for Pulmonary Fibrosis
05-17-2021 Treatment of Major Depressive Disorder by Low Dose Interleukin-2
04-13-2021 Amelioration and Treatment of Opioid Addiction
03-29-2021 Compositions Capable of Stimulating Immunity Towards Tumor Blood Vessels
03-23-2021 Chimeric Cells Comprising Dendritic Cells and Endothelial Cells Resembling Tumor Endothelium
03-16-2021 Pluripotent Stem Cell Derived Dendritic Cells and Engineered Dendritic Cells for Cancer Immunotherapy
03-04-2021 Therapeutic Monocytes for Prevention of Suicidal Ideation
02-22-2021 Ex Vivo Generation of Immunocytes Recognizing Brother of the Regulator of Imprinted Sites (BORIS) Expressing Cancer Stem Cells
02-08-2021 Stimulation of Natural Kill Cell Memory by Administration of Dendritic Cells
01-26-2021 Stimulation of Dendritic Cell Activity by Homotaurine and Analogues Thereof
12-21-2020 Immunotherapy for Opioid Addiction
12-08-2020 Treatment of Major Depressive Disorder and Suicidal Ideations Through Stimulation of Hippocampal Neurogenesis Utilizing Plant-Based Approaches
11-24-2020 Stimulation of NK Cell Activity by QuadraMune Alone and together with Metformin
10-27-2020 Protection/Regeneration of Neurological Function by Endothelial Protection/Rejuvenation using Stem Cells for Treatment of Conditions such as Chronic Traumatic Encephalopathy and Schizophrenia
10-18-2020 Nutraceutical Reduction Prevention and/or Reversion of Multiple Sclerosis
09-24-2020 Personalized Immunotherapies for Reduction of Brain Inflammation and Suicide Prevention
09-14-2020 Immunotherapy of Schizophrenia and Schizophrenia Associated Suicidal Ideation/Suicide
08-28-2020 Upregulation of Therapeutic T Regulatory Cells and Suppression of Suicidal Ideations in Response to Inflammation by Administration of Nutraceutical Compositions Alone or Combined with Minocycline
08-21-2020 Methods of Determining Risk of Suicide and/or Suicidal Ideation by Immunological Assessment
08-05-2020 Prevention of Neuroinflammation associated Memory Loss Using Nutraceutical Compositions
07-28-2020 Neuroprotection and Neuroregeneration by Pterostilbene and Compositions Thereof
07-22-2020 Additive and/or Synergistic Combinations of Metformin with Nutraceuticals for the Prevention, Inhibition and Treatment of SARS-Cov-2 and Associated COVID-19
07-13-2020 Prevention of Pathological Coagulation in COVID-19 and other Inflammatory Conditions
06-30-2020 Augmentation of Natural Killer Cell Activity and Induction of Cytotoxic Immunity Using Leukocyte Lysate Activated Allogeneic Dendritic Cells: StemVacs™
06-22-2020 Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity
06-15-2020 Nutraceuticals for Suppressing Indolamine 2,3 Deoxygenase
06-11-2020 Nutraceuticals for Reducing Myeloid Suppressor Cells
05-11-2020 Treatment of COVID-19 Lung Injury Using Umbilical Cord Plasma Based Compositions
05-04-2020 Nutraceuticals for the Prevention, Inhibition and Treatment of SARS-Cov-2 and Associated COVID-19
11-04-19 Cellular, Organ, and Whole-Body Rejuvenation Utilizing Cord Blood Plasma and Pterostilbene
09-09-19 Pterostilbene and Formulations Thereof for Protection of Hematopoiesis from Chemotherapy and Radiation
01-21-19 Prevention and Reversion of Chronic Traumatic Encephalopathy through Administration of “Educated” Monocytes and Progenitors Thereof
01-09-19 Autologous Neurogenic Cells and Uses Thereof for Professional Athletes at Risk of Chronic Traumatic Encephalopathy
12-05-18 Treatment of Chronic Traumatic Encephalopathy via RNA Administration
09-25-18 Pterostilbene and Formulations Thereof for Treatment of Pathological Immune Activation
09-17-18 Pterostilbene and Compositions Thereof for Prevention and Treatment of Chronic Traumatic Encephalopathy
08-13-18 Enhancement of Ozone Therapy using Pterostilbene
10-08-17 Synergistic Inhibition of Glioma Using Pterostilbene and Analogues Thereof
03-29-17 Methods of Re-Activating Dormant Memory Cells with Anticancer Activity
03-29-17 Augmentation of Anti-Tumor Immunity by Mifepristone and Analogues Thereof
03-29-17 Activated Leukocyte Extract for Repair of Innate Immunity in Cancer Patients
03-29-17 Stimulation of Immunity to Tumor Stem Cell Specific Proteins by Peptide Immunization
03-29-17 Targeting the Tumor Microenvironment through Nutraceutical Based Immunoadjuvants
04-27-16 Augmentation Of Stem Cell Activity Using Pterostilbene And Compositions Containing Pterostilbene
09-25-15 A Medical Device For Reducing The Risk Of Preterm-Labor And Preterm-Birth
09-15-15 Diagnostic Methods For The Assessment Of Pregnancy Complications
09-02-15 Preventative Methods and Therapeutic or Pharmaceutical Compositions for the Treatment or Prevention of Pregnancy Complications
07-08-15 Augmentation of Oncology Immunotherapies by Pterostilbene Containing Compositions
Post Reply